Search

School Age Children are not at Substantial Risk from COVID-19 Infection

Updated: Oct 8, 2021

If school-aged children were at significant health risk from COVID-19 infection, or if immunity resulting from natural infection were not effective, then the cost to benefit conclusions would be different. However, for young people 18 and under, successful recovery rates are extremely high, rates of long-term COVID-19 symptoms are low, and natural immunity is proving strong. Therefore, the risks of side effects from the vaccination likely outweigh the benefits for a majority of students.[1][2][3] And, per the latest studies, for students carrying antibodies from previous COVID-19 infection, the known side effects and long-term risks from vaccination most assuredly outweigh the risks of contracting COVID-19.[4][5][6]

[1] https://www.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/children-and-covid-19-state-level-data-report/


[2] https://www.npr.org/sections/coronavirus-live-updates/2021/08/10/1026375608/nearly-94-000-kids-got-covid-19-last-week-they-were-15-of-all-new-infections [3] https://www.scmp.com/news/world/middle-east/article/3146656/past-covid-19-reduces-risk-reinfection-delta-variant-pfizer [4] https://www.statista.com/statistics/1191568/reported-deaths-from-covid-by-age-us/ [5] https://www.statista.com/statistics/1254271/us-total-number-of-covid-cases-by-age-group/ [6] https://www.medpagetoday.com/opinion/marty-makary/93029

8 views0 comments

Recent Posts

See All

We're weren't As of October 7, the Florida Surgeon General recommends against the mRNA vaccines for males aged 18-39 years old. The Florida Health Department still recommends against their use in heal

The COVID-19 mRNA vaccines are likely killing people. And, likely killing people who were least likely to die, or to get very sick, from a COVID-19 infection. But, with the wind in big pharma's sail

Is the FDA panel using their brains. Maybe increasing scrutiny has forced their brains to work. “All the FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) could agree about o